Whole-Genome Sequencing for Drug Resistance Profile Prediction in

Antitubercular Agents / pharmacology Democratic Republic of the Congo Drug Resistance, Multiple, Bacterial / genetics Ethambutol / pharmacology Genome, Bacterial / genetics Genotype Humans Microbial Sensitivity Tests / methods Mutation / genetics Mycobacterium tuberculosis / drug effects Peru Phenotype Switzerland Thailand Tuberculosis, Multidrug-Resistant / drug therapy Whole Genome Sequencing / methods
Mycobacterium tuberculosis drug resistance drug resistance level prediction quantitative phenotypic drug susceptibility testing whole-genome sequencing

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
04 2019
Historique:
received: 15 10 2018
accepted: 25 01 2019
pubmed: 6 2 2019
medline: 27 2 2020
entrez: 6 2 2019
Statut: epublish

Résumé

Whole-genome sequencing allows rapid detection of drug-resistant

Identifiants

DOI: 10.1128/AAC.02175-18 PMID: 30718257 PMC: PMC6496161
pubmed: 30718257
pii: AAC.02175-18
doi: 10.1128/AAC.02175-18
pmc: PMC6496161
pii:
doi:

Substances chimiques

Antitubercular Agents 0
Ethambutol 8G167061QZ

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : U01 AI096299
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069923
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069919
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069907
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069924
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Gygli et al.

Références

Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Sci Rep. 2018 Jun 26;8(1):9676
pubmed: 29946139
Antimicrob Agents Chemother. 2014;58(1):11-8
pubmed: 24100497
Am J Respir Crit Care Med. 2016 Sep 1;194(5):621-30
pubmed: 26910495
Nat Genet. 2014 Mar;46(3):279-86
pubmed: 24464101
Antimicrob Agents Chemother. 2012 May;56(5):2420-7
pubmed: 22330913
Int J Epidemiol. 2012 Oct;41(5):1256-64
pubmed: 21593078
Infect Dis (Lond). 2016;48(1):1-17
pubmed: 26167849
Int J Mycobacteriol. 2016 Mar;5(1):1-6
pubmed: 26927983
J Clin Microbiol. 2017 Jun;55(6):1871-1882
pubmed: 28381603
J Clin Microbiol. 2016 Aug;54(8):2058-67
pubmed: 27225403
Clin Orthop Relat Res. 2005 Aug;(437):3-6
pubmed: 16056018
N Engl J Med. 2015 Nov 12;373(20):1986-8
pubmed: 26559594
FEMS Microbiol Rev. 2017 May 1;41(3):354-373
pubmed: 28369307
Nat Genet. 2013 Oct;45(10):1190-7
pubmed: 23995136
RNA. 2016 Dec;22(12):1836-1843
pubmed: 27698071
Diagn Microbiol Infect Dis. 2016 Jun;85(2):177-81
pubmed: 27036978
J Clin Microbiol. 2014 Mar;52(3):940-6
pubmed: 24403306
Clin Infect Dis. 2018 Aug 16;67(5):708-716
pubmed: 29514175
EBioMedicine. 2016 Jul;9:228-237
pubmed: 27333026
Clin Infect Dis. 2015 Oct 15;61Suppl 3:S141-6
pubmed: 26409275
J Clin Microbiol. 2016 Jun;54(6):1624-1630
pubmed: 27076658
PLoS Med. 2015 Sep 29;12(9):e1001880
pubmed: 26418737
Lancet Infect Dis. 2015 Oct;15(10):1193-1202
pubmed: 26116186
J Antimicrob Chemother. 1995 Mar;35(3):381-90
pubmed: 7782254
J Antimicrob Chemother. 2018 May 1;73(5):1138-1151
pubmed: 29360989
Evol Med Public Health. 2013 Jan;2013(1):65-74
pubmed: 24481187
Bull World Health Organ. 2012 Sep 1;90(9):693-8
pubmed: 22984314
Clin Microbiol Infect. 2011 Aug;17(8):1128-34
pubmed: 21631641
N Engl J Med. 2018 Oct 11;379(15):1403-1415
pubmed: 30280646
Antimicrob Agents Chemother. 2018 Aug 27;62(9):
pubmed: 29941636
Clin Microbiol Infect. 2017 Mar;23(3):154-160
pubmed: 27810467
J Clin Microbiol. 2009 Jun;47(6):1773-80
pubmed: 19339475
Int J Tuberc Lung Dis. 2016 Jan;20(1):24-42
pubmed: 26688526
PLoS Biol. 2017 Apr 18;15(4):e2001741
pubmed: 28419091
Genome Med. 2015 May 27;7(1):51
pubmed: 26019726
J Clin Microbiol. 2016 Jul;54(7):1862-1870
pubmed: 27194683
Antimicrob Agents Chemother. 2012 Jun;56(6):3047-53
pubmed: 22470121
Eur Respir J. 2017 Dec 28;50(6):
pubmed: 29284687
Sci Rep. 2017 Nov 7;7(1):14647
pubmed: 29116204

Auteurs

Sebastian M Gygli (SM)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Peter M Keller (PM)

Institute of Medical Microbiology, University of Zürich, Zürich, Switzerland.
Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Marie Ballif (M)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Nicolas Blöchliger (N)

Institute of Medical Microbiology, University of Zürich, Zürich, Switzerland.

Rico Hömke (R)

Institute of Medical Microbiology, University of Zürich, Zürich, Switzerland.
National Center for Mycobacteria, University of Zürich, Zürich, Switzerland.

Miriam Reinhard (M)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Chloé Loiseau (C)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Claudia Ritter (C)

Institute of Medical Microbiology, University of Zürich, Zürich, Switzerland.
National Center for Mycobacteria, University of Zürich, Zürich, Switzerland.

Peter Sander (P)

Institute of Medical Microbiology, University of Zürich, Zürich, Switzerland.
National Center for Mycobacteria, University of Zürich, Zürich, Switzerland.

Sonia Borrell (S)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Jimena Collantes Loo (J)

Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.

Anchalee Avihingsanon (A)

HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
TB Research Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Joachim Gnokoro (J)

Centre de Prise en Charge de Recherche et de Formation, Yopougon, Abidjan, Côte d'Ivoire.

Marcel Yotebieng (M)

College of Public Health, Ohio State University, Columbus, Ohio, USA.

Matthias Egger (M)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.

Sebastien Gagneux (S)

Swiss Tropical and Public Health Institute, Basel, Switzerland sebastien.gagneux@swisstph.ch boettger@imm.uzh.ch.
University of Basel, Basel, Switzerland.

Erik C Böttger (EC)

Institute of Medical Microbiology, University of Zürich, Zürich, Switzerland sebastien.gagneux@swisstph.ch boettger@imm.uzh.ch.
National Center for Mycobacteria, University of Zürich, Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Antituberculeux › Whole-Genome Sequencing for Drug Resistance...
questionsmedicales.fr › Régions géographiques › Afrique › Afrique subsaharienne › Afrique centrale › République démocratique du Congo › Whole-Genome Sequencing for Drug Resistance...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Multirésistance aux médicaments › Multirésistance bactérienne aux médicaments › Whole-Genome Sequencing for Drug Resistance...
questionsmedicales.fr › Composés chimiques organiques › Amines › Polyamines › Diamines › Éthylènediamines › Éthambutol › Whole-Genome Sequencing for Drug Resistance...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Génome microbien › Génome bactérien › Whole-Genome Sequencing for Drug Resistance...
questionsmedicales.fr › Phénomènes génétiques › Génotype › Whole-Genome Sequencing for Drug Resistance...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Whole-Genome Sequencing for Drug Resistance...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Whole-Genome Sequencing for Drug Resistance...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Whole-Genome Sequencing for Drug Resistance...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Bâtonnets à Gram positif › Bâtonnets asporogènes à Gram positif › Bâtonnets asporogènes réguliers à Gram positif › Mycobacteriaceae › Mycobacterium › Mycobacterium tuberculosis › Whole-Genome Sequencing for Drug Resistance...
questionsmedicales.fr › Régions géographiques › Amériques › Amérique du Sud › Pérou › Whole-Genome Sequencing for Drug Resistance...
questionsmedicales.fr › Phénomènes génétiques › Phénotype › Whole-Genome Sequencing for Drug Resistance...
questionsmedicales.fr › Régions géographiques › Europe › Suisse › Whole-Genome Sequencing for Drug Resistance...
questionsmedicales.fr › Régions géographiques › Asie › Asie du Sud-Est › Thaïlande › Whole-Genome Sequencing for Drug Resistance...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Infections à Actinomycetales › Infections à Mycobacterium › Tuberculose › Tuberculose multirésistante › Whole-Genome Sequencing for Drug Resistance...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Séquençage du génome entier › Whole-Genome Sequencing for Drug Resistance...